Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 1, 1993 - Issue 3
71
Views
62
CrossRef citations to date
0
Altmetric
Original Article

Synthesis of NG, NG Dimethylarginine by Human Endothelial Cells

, , , &
Pages 137-140 | Received 01 Jun 1993, Published online: 13 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ellen S. Kang, Taylor B. Cates, Dyette N. Harper, Thomas M. Chiang, Linda K. Myers, Sergio R. Acchiardo & Masumi Kimoto. (2001) An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells. Free Radical Research 35:6, pages 693-707.
Read now
Anders Pettersson, Thomas Hedner & Ian Milsom. (1998) Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstetricia et Gynecologica Scandinavica 77:8, pages 808-813.
Read now
Giorgio Bertolini & Mario Aquino. (1994) Patent Update Cardiovascular & Renal: Nitric oxide synthase inhibitors: recent advances. Expert Opinion on Therapeutic Patents 4:11, pages 1339-1345.
Read now

Articles from other publishers (58)

Shan Huang, Dajin Zou, Wenfang Peng, Xiaohong Jiang, Kan Shao, Lili Xia & Yubin Tang. (2016) The prediction roles of asymmetric dimethyl-arginine, adiponectin and apelin for macroangiopathy in patients with impaired glucose regulation. Annales d'Endocrinologie 77:6, pages 633-640.
Crossref
Edimar Cristiano Pereira, Marcelo Chiara Bertolami, André Arpad Faludi, Osmar Monte, Hermes Toros Xavier, Tiago Veiga Pereira & Dulcineia Saes Parra Abdalla. (2015) Predictive Potential of Twenty-Two Biochemical Biomarkers for Coronary Artery Disease in Type 2 Diabetes Mellitus. International Journal of Endocrinology 2015, pages 1-8.
Crossref
Sara Franceschelli, Alessio Ferrone, Mirko Pesce, Graziano Riccioni & Lorenza Speranza. (2013) Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease. International Journal of Molecular Sciences 14:12, pages 24412-24421.
Crossref
Maike Anderssohn & Rainer Böger. 2013. Endothelium. Endothelium 198 228 .
Ruben Esse, Monica S. Rocha, Madalena Barroso, Cristina Florindo, Tom Teerlink, Robert M. Kok, Yvo M. Smulders, Isabel Rivera, Paula Leandro, Pieter Koolwijk, Rita Castro, Henk J. Blom & Isabel Tavares de Almeida. (2013) Protein Arginine Methylation Is More Prone to Inhibition by S-Adenosylhomocysteine than DNA Methylation in Vascular Endothelial Cells. PLoS ONE 8:2, pages e55483.
Crossref
Aleksandra Jaźwińska-Kozuba, Jens Martens-Lobenhoffer, Andrzej Surdacki, Olga Kruszelnicka, Jarosław Rycaj, Urszula Godula-Stuglik & Stefanie Bode-Böger. (2012) Associations between Endogenous Dimethylarginines and Renal Function in Healthy Children and Adolescents. International Journal of Molecular Sciences 13:12, pages 15464-15474.
Crossref
Makoto Tanaka, Tomohiro Osanai, Reiichi Murakami, Satoko Sasaki, Hirofumi Tomita, Naotaka Maeda, Kei Satoh, Koji Magota & Ken Okumura. (2006) Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine. Journal of Hypertension 24:3, pages 489-497.
Crossref
Duygu Çevik, Özlem Unay, Fatih Durmusoglu, Türkan Yurdun & A Serpil Bilsel. (2016) Plasma markers of NO synthase activity in women after ovarian hyperstimulation: influence of estradiol on ADMA. Vascular Medicine 11:1, pages 7-12.
Crossref
Katari A. Carello, Steven E. Whitesall, Mary C. Lloyd, Scott S. Billecke & Louis G. D'Alecy. (2006) Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats. American Journal of Physiology-Heart and Circulatory Physiology 290:1, pages H209-H216.
Crossref
M. Ata Seçilmiş, Yusuf Karataş, Özlem Yorulmaz, Kansu Büyükafşar, Ergin Şingirik, Figen Doran, Tamer C. Inal & Atilla Dikmen. (2005) Protective Effect of <i>L</i>-Arginine Intake on the Impaired Renal Vascular Responses in the Gentamicin-Treated Rats. Nephron Physiology 100:2, pages p13-p20.
Crossref
Yun-Feng Fu, Yan Xiong & Zheng Guo. (2005) A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats. European Journal of Pharmacology 508:1-3, pages 167-175.
Crossref
Rainer H. Böger. (2004) Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the “L-Arginine Paradox” and Acts as a Novel Cardiovascular Risk Factor. The Journal of Nutrition 134:10, pages 2842S-2847S.
Crossref
Jennifer Albsmeier, Edzard Schwedhelm, Friedrich Schulze, Mariola Kastner & Rainer H Böger. (2004) Determination of NG,NG-dimethyl-l-arginine, an endogenous NO synthase inhibitor, by gas chromatography–mass spectrometry. Journal of Chromatography B 809:1, pages 59-65.
Crossref
Patrick VallanceJames Leiper. (2004) Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 24:6, pages 1023-1030.
Crossref
Tomohiro OsanaiMasayuki SaitohSatoko SasakiHirofumi TomitaToshiro MatsunagaKen Okumura. (2003) Effect of Shear Stress on Asymmetric Dimethylarginine Release From Vascular Endothelial Cells. Hypertension 42:5, pages 985-990.
Crossref
Rainer H Böger. (2016) Asymmetric dimethylarginine (ADMA) modulates endothelial function - therapeutic implications. Vascular Medicine 8:3, pages 149-151.
Crossref
Vinod AchanMichael BroadheadMohammed MalakiGuy WhitleyJames LeiperRaymond MacAllisterPatrick Vallance. (2003) Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase. Arteriosclerosis, Thrombosis, and Vascular Biology 23:8, pages 1455-1459.
Crossref
Alexandra Martin, Michael R. Komada & David C. Sane. (2002) Abnormal angiogenesis in diabetes mellitus. Medicinal Research Reviews 23:2, pages 117-145.
Crossref
Rainer H. Böger. (2003) Association of Asymmetric Dimethylarginine and Endothelial Dysfunction. Clinical Chemistry and Laboratory Medicine 41:11.
Crossref
Takahiro Maeda, Toshihiro Yoshimura & Hitoshi Okamura. (2016) Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, in Maternal and Fetal Circulation. Journal of the Society for Gynecologic Investigation 10:1, pages 2-4.
Crossref
K. Y. Lin, A. Ito, T. Asagami, P. S. Tsao, S. Adimoolam, M. Kimoto, H. Tsuji, G. M. Reaven & J. P. Cooke. (2002) Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase. Circulation 106:8, pages 987-992.
Crossref
HITOSHI MASUDA, TOSHIHIKO TSUJII, TETSUO OKUNO, KAZUNORI KIHARA, MORITAKA GOTO & HIROSHI AZUMA. (2002) Localization and Role of Nitric Oxide Synthase and Endogenous Nitric Oxide Synthase Inhibitors in the Rabbit Lower Urinary Tract. The Journal of Urology, pages 2235-2240.
Crossref
HITOSHI MASUDA, TOSHIHIKO TSUJII, TETSUO OKUNO, KAZUNORI KIHARA, MORITAKA GOTO & HIROSHI AZUMA. (2002) Localization and Role of Nitric Oxide Synthase and Endogenous Nitric Oxide Synthase Inhibitors in the Rabbit Lower Urinary Tract. Journal of Urology 167:5, pages 2235-2240.
Crossref
Akira Ito, Kensuke Egashira, Takahiro Narishige, Kouhei Muramatsu & Akira Takeshita. (2002) Angiotensin-Converting Enzyme Activity is Involved in the Mechanism of Increased Endogenous Nitric Oxide Synthase Inhibitor in Patients With Type 2 Diabetes Mellitus. Circulation Journal 66:9, pages 811-811.
Crossref
Markus Knipp, John M. Charnock, C. David Garner & Milan Vašák. (2001) Structural and Functional Characterization of the Zn(II) Site in Dimethylargininase-1 (DDAH-1) from Bovine Brain. Journal of Biological Chemistry 276:44, pages 40449-40456.
Crossref
Ellen S. Kang, Taylor B. Cates, Don E. Miles, Marjorie T. Tevlin & Sergio R. Acchiardo. (2001) Reversible Sequestration of Nitric Oxide by Hemoglobin During Hemodialysis in End-Stage Renal Disease. The American Journal of the Medical Sciences 321:2, pages 113-123.
Crossref
Akira Ito, Kensuke Egashira, Takahiro Narishige, Kouhei Muramatsu & Akira Takeshita. (2001) Renin-Angiotensin System is Involved in the Mechanism of Increased Serum Asymmetric Dimethylarginine in Essential Hypertension. Japanese Circulation Journal 65:9, pages 775-778.
Crossref
Rainer H Böger, Stefanie M Bode-Böger, Philip S Tsao, Patrick S Lin, Jason R Chan & John P Cooke. (2000) An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. Journal of the American College of Cardiology 36:7, pages 2287-2295.
Crossref
Ian S. Young & Jayne V. Woodside. (2000) Folate and homocysteine. Current Opinion in Clinical Nutrition and Metabolic Care 3:6, pages 427-432.
Crossref
Ali FardCatherine H. TuckJoshua A. DonisRobert SciaccaMarco R. Di TullioHenry D. WuTodd A. BryantNiem-Tzu ChenMargarita Torres-TamayoRavichandran RamasamyLars BerglundHenry N. GinsbergShunichi HommaPaul J. Cannon. (2000) Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology 20:9, pages 2039-2044.
Crossref
Rainer H. BögerKarsten SydowJürgen BorlakThomas ThumHenrike LenzenBibiana SchubertDimitrios TsikasStefanie M. Bode-Böger. (2000) LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial Cells. Circulation Research 87:2, pages 99-105.
Crossref
Rainer H. BögerStefanie M. Bode-BögerKarsten SydowDonald D. HeistadSteven R. Lentz. (2000) Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or Hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology 20:6, pages 1557-1564.
Crossref
Pablo Muriel. (2000) Regulation of nitric oxide synthesis in the liver. Journal of Applied Toxicology 20:3, pages 189-195.
Crossref
Jason R. ChanRainer H. BögerStefanie M. Bode-BögerOranee TangphaoPhilip S. TsaoTerrence F. BlaschkeJohn P. Cooke. (2000) Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans. Arteriosclerosis, Thrombosis, and Vascular Biology 20:4, pages 1040-1046.
Crossref
Naoto FujiwaraTomohiro OsanaiTakaatsu KamadaTakeshi KatohKoki TakahashiKen Okumura. (2000) Study on the Relationship Between Plasma Nitrite and Nitrate Level and Salt Sensitivity in Human Hypertension. Circulation 101:8, pages 856-861.
Crossref
Fickling, Holden, Cartwright, Nussey, Vallance & Whitley. (2001) Regulation of macrophage nitric oxide synthesis by endothelial cells: a role for N G ,N G ‐dimethylarginine . Acta Physiologica Scandinavica 167:2, pages 145-150.
Crossref
D. Gattullo, P. Pagliaro, N.A. Marsh & G. Losano. (1999) New insights into nitric oxide and coronary circulation. Life Sciences 65:21, pages 2167-2174.
Crossref
Akira ItoPhilip S. TsaoShanthi AdimoolamMasumi KimotoTadashi OgawaJohn P. Cooke. (1999) Novel Mechanism for Endothelial Dysfunction. Circulation 99:24, pages 3092-3095.
Crossref
Andrzej Surdacki, Michał Nowicki, Joerg Sandmann, Dimitrios Tsikas, Rainer H. Boeger, Stephanie M. Bode-Boeger, Olga Kruszelnicka-Kwiatkowska, Franciszek Kokot, Jacek S. Dubiel & Juergen C. Froelich. (1999) Reduced Urinary Excretion of Nitric Oxide Metabolites and Increased Plasma Levels of Asymmetric Dimethylarginine in Men with Essential Hypertension. Journal of Cardiovascular Pharmacology 33:4, pages 652-658.
Crossref
ELLEN S. KANG, MARJORIE T. TEVLIN, YU BO WANG, THOMAS M. CHIANG, RAUL CARDENAS, LINDA K. MYERS & SERGIO R. ACCHIARDO. (1999) Hemodialysis Hypotension: Interaction of Inhibitors, iNOS, and the Interdialytic Period. The American Journal of the Medical Sciences 317:1, pages 9-21.
Crossref
Rudi Busse & Ingrid Fleming. (1999) Nitric oxide, nitric oxide synthase, and hypertensive vascular disease. Current Hypertension Reports 1:1, pages 88-95.
Crossref
R. H. Boger, S. M. Bode-Boger, A. Szuba, P. S. Tsao, J. R. Chan, O. Tangphao, T. F. Blaschke & J. P. Cooke. (1998) Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction : Its Role in Hypercholesterolemia. Circulation 98:18, pages 1842-1847.
Crossref
Stefanie M. Bode‐Böger, Rainer H. Böger, Andrea Galland, Dimitrios Tsikas & Jürgen C. Frölich. (2002) L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationship. British Journal of Clinical Pharmacology 46:5, pages 489-497.
Crossref
Jun Sato, Hiroshi Masuda, Satoru Tamaoki, Hidehisa Hamasaki, Kazuhiro Ishizaka, Osamu Matsubara & Hiroshi Azuma. (2009) Endogenous asymmetrical dimethylarginine and hypertension associated with puromycin nephrosis in the rat. British Journal of Pharmacology 125:3, pages 469-476.
Crossref
Desmond P. Holden, Sara A. Fickling, Guy St.J. Whitley & Stephen S. Nussey. (1998) Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. American Journal of Obstetrics and Gynecology 178:3, pages 551-556.
Crossref
Akihiro Tojo, William J. Welch, Viviane Bremer, Masumi Kimoto, Kenjiro Kimura, Masao Omata, Tadashi Ogawa, Patrick Vallance & Christopher S. Wilcox. (1997) Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney International 52:6, pages 1593-1601.
Crossref
Kazuhide Ayajiki, Hideshi Hayashida, Tomio Okamura & Noboru Toda. (1997) Pelvic nerve stimulation-induced pressor responses in corpus cavernosum of anesthetized dogs. American Journal of Physiology-Heart and Circulatory Physiology 273:5, pages H2141-H2145.
Crossref
Chulananda D.A. Goonasekera, Daryl D. Rees, Patrick Woolard, Anthony Frend, Vanita Shah & Michael J. Dillon. (1997) Nitric oxide synthase inhibitors and hypertension in children and adolescents. Journal of Hypertension 15:8, pages 901-909.
Crossref
Rainer H. BögerStefanie M. Bode-BögerWolfgang ThieleWolfgang JunkerKlaus AlexanderJürgen C. Frölich. (1997) Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease. Circulation 95:8, pages 2068-2074.
Crossref
Jens Meyer, Nadja Richter & Markus Hecker. (1997) High-Performance Liquid Chromatographic Determination of Nitric Oxide Synthase-Related Arginine Derivativesin Vitroandin Vivo. Analytical Biochemistry 247:1, pages 11-16.
Crossref
Hidehiro MatsuokaShingo ItohMasumi KimotoKeisuke KohnoOsamu TamaiYoshifumi WadaHideo YasukawaGensho IwamiSeiya OkudaTsutomu Imaizumi. (1997) Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental Hypertension. Hypertension 29:1, pages 242-247.
Crossref
Raymond J. MacAllister, Heather Parry, Masumi Kimoto, Tadashi Ogawa, Rachel J. Russell, Harold Hodson, Guy St.J. Whitley & Patrick Vallance. (2012) Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. British Journal of Pharmacology 119:8, pages 1533-1540.
Crossref
K. A. HINCKLEY, S. FEARN, B. R. HOWARD & I. W. HENDERSON. (2010) Nitric oxide donors as treatment for grass induced acute laminitis in ponies. Equine Veterinary Journal 28:1, pages 17-28.
Crossref
Patrick Vallance. 1996. Nitric Oxide Part B: Physiological and Pathological Processes. Nitric Oxide Part B: Physiological and Pathological Processes 453 459 .
Randall White, Darren Barefield, Sunanda Ram & Jack Work. (1995) Peritoneal dialysis solutions reverse the hemodynamic effects of nitric oxide synthesis inhibitors. Kidney International 48:6, pages 1986-1993.
Crossref
Raymond J. MacAllister, Sara A. Fickling, Guy St. J. Whitley & Patrick Vallance. (2012) Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. British Journal of Pharmacology 112:1, pages 43-48.
Crossref
Raymond J. MacAllister, Guy St J. Whitley & Patrick Vallance. (1994) Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney International 45:3, pages 737-742.
Crossref
S.M. Gardiner, P.A. Kemp, T. Bennett, R.M.J. Palmer & S. Moncada. (2012) Regional and cardiac haemodynamic effects of N G , N G ,dimethyl‐ l ‐arginne and their reversibility by vasodilators in conscious rats . British Journal of Pharmacology 110:4, pages 1457-1464.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.